AR245504A1 - Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec. - Google Patents

Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec.

Info

Publication number
AR245504A1
AR245504A1 AR91319296A AR31929691A AR245504A1 AR 245504 A1 AR245504 A1 AR 245504A1 AR 91319296 A AR91319296 A AR 91319296A AR 31929691 A AR31929691 A AR 31929691A AR 245504 A1 AR245504 A1 AR 245504A1
Authority
AR
Argentina
Prior art keywords
active
spec
lactis
abundant protein
lactococous
Prior art date
Application number
AR91319296A
Other languages
English (en)
Spanish (es)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of AR245504A1 publication Critical patent/AR245504A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/853Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AR91319296A 1990-03-22 1991-03-22 Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec. AR245504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006400A GB9006400D0 (en) 1990-03-22 1990-03-22 Bacterial vectors

Publications (1)

Publication Number Publication Date
AR245504A1 true AR245504A1 (es) 1994-01-31

Family

ID=10673033

Family Applications (1)

Application Number Title Priority Date Filing Date
AR91319296A AR245504A1 (es) 1990-03-22 1991-03-22 Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec.

Country Status (22)

Country Link
US (1) US5559007A (Direct)
EP (1) EP0449770B1 (Direct)
JP (1) JPH04211384A (Direct)
KR (1) KR910016930A (Direct)
AR (1) AR245504A1 (Direct)
AT (1) ATE174055T1 (Direct)
AU (1) AU643511B2 (Direct)
BR (1) BR9101137A (Direct)
CA (1) CA2038706A1 (Direct)
DE (1) DE69130544T2 (Direct)
DK (1) DK0449770T3 (Direct)
ES (1) ES2125864T3 (Direct)
FI (1) FI911367L (Direct)
GB (1) GB9006400D0 (Direct)
HU (1) HUT57263A (Direct)
IE (1) IE910948A1 (Direct)
MX (1) MX25027A (Direct)
NO (1) NO911138L (Direct)
NZ (1) NZ237506A (Direct)
PT (1) PT97081B (Direct)
TW (1) TW213488B (Direct)
ZA (1) ZA912114B (Direct)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286361A (en) * 1992-10-19 1994-02-15 Regents Of The University Of California Magnetically attached sputter targets
WO1996032486A1 (en) * 1995-04-11 1996-10-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
ES2185972T3 (es) * 1996-09-06 2003-05-01 Bioteknologisk Inst Sistema de expresion regulable en bacterias productoras de acido lactico.
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
WO2004001020A2 (en) 2002-06-19 2003-12-31 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Methods and means to promote gut absorption
EP1560935A2 (en) * 2002-11-15 2005-08-10 VIB vzw Self-containing lactobacillus strain
RU2420569C2 (ru) 2005-11-29 2011-06-10 Актогеникс Нв Индукция толерантности к антигенам через слизистую
US8759088B2 (en) 2007-01-12 2014-06-24 Actogenix N.V. Lactococcus promoters and uses thereof
ES2666658T3 (es) 2007-01-25 2018-05-07 Intrexon Actobiotics Nv Tratamiento de enfermedad inmune mediante suministro a la mucosa de antígenos
JP5126879B2 (ja) * 2007-07-13 2013-01-23 独立行政法人海洋研究開発機構 新規dna断片およびそれを含む組換えベクター、それらによって形質転換された形質転換体、ならびにそれらの利用
EP3933029A3 (en) 2008-09-29 2022-03-23 Intrexon Actobiotics NV Reduced colonization of microbes at the mucosa
DK2424972T3 (da) 2009-04-30 2013-10-14 Actogenix Nv Kryobeskyttende midler til frysetørring af mælkesyrebakterier
EP2275527A1 (en) 2009-07-17 2011-01-19 ActoGeniX NV Animal component-free culture medium for bacterial fermentation
US20120183503A1 (en) 2009-09-29 2012-07-19 Actogenix N.V. Lactobacillus and streptococcus promoters and uses thereof
JP2013530187A (ja) 2010-06-17 2013-07-25 ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 炎症性疾患を治療するための組成物及び方法。
DK2714912T3 (en) 2011-06-01 2018-08-13 Intrexon Actobiotics Nv POLYCISTRONIC EXPRESSION SYSTEM FOR BACTERIA
JP6329903B2 (ja) 2011-09-23 2018-05-23 イントレクソン・アクトバイオテイクス・エヌブイIntrexon Actobiotics NV 改変されたグラム陽性菌及びその使用
JP6117212B2 (ja) 2011-09-23 2017-04-19 イントレクソン・アクトバイオテイクス・エヌブイIntrexon Actobiotics NV 改変されたグラム陽性菌及びその使用
CA3011331C (en) 2016-01-14 2025-05-13 Intrexon Actobiotics N.V. COMPOSITIONS AND TREATMENT METHODS FOR TYPE 1 DIABETES
CN110637089B (zh) * 2017-03-22 2024-08-02 新加坡科技研究局 蛋白质表达构建体及其方法
CN116144690A (zh) * 2022-08-23 2023-05-23 江西省科学院微生物研究所(江西省流域生态研究所) 一种大肠杆菌与乳酸菌的穿梭载体pDXA及构建方法与应用
WO2025233675A1 (en) 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings
WO2025253171A1 (en) 2024-06-04 2025-12-11 Institut Pasteur Characterization of viruses associated with the zoonotic fish-borne oncogenic liver flukes and applications thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8400687A (nl) 1984-03-02 1985-10-01 Unilever Nv Recombinant plasmiden; recombinant plasmiden bevattende bacterien; werkwijze voor het bereiden of vervaardigen van een zuivelproduct; werkwijze voor het bereiden van een eiwit.
DE3583361D1 (de) 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
NL8503316A (nl) * 1985-11-29 1987-06-16 Stichting Nl I Zuivelonderzoek Werkwijze voor het bereiden van proteinen met behulp van gastheer-organismen, in het bijzonder melkzuurbacterien, welke recombinant dna-plasmiden met een hoge replicon-aktiviteit en een hoge promotor-aktiviteit voor het betreffende proteine-coderende gen bevatten, de van dergelijke recombinant dna-plasmiden voorziene gastheerorganismen, de recombinant dna-plasmiden zelve, de replicon-aktiviteit en promotor-aktiviteit coderende dna-fragmenten, alsmede de verkregen proteinen.
EP0316677A3 (en) 1987-11-13 1990-04-25 Miles Inc. Method for cloning in lactic acid bacteria
NL9000753A (nl) * 1990-03-30 1991-10-16 Nl Zuivelonderzoek Inst Dna-fragment, ten minste coderend voor een deel van het extracellulaire eiwit met een schijnbaar molecuulgewicht van 60 kda van lactococcus lactis stammen zoals de lactococcus lactis ssp. lactis stam mg1363, combinaties hiervan met voor homologe of heterologe eiwitten coderende dna-sequenties alsmede de hiermee verkregen homologe en heterologe eiwitten.

Also Published As

Publication number Publication date
NO911138L (no) 1991-09-23
EP0449770B1 (en) 1998-12-02
PT97081B (pt) 1998-07-31
ZA912114B (en) 1992-01-29
JPH04211384A (ja) 1992-08-03
DK0449770T3 (da) 1999-06-23
FI911367A7 (fi) 1991-09-23
ATE174055T1 (de) 1998-12-15
ES2125864T3 (es) 1999-03-16
AU7355891A (en) 1991-10-03
TW213488B (Direct) 1993-09-21
PT97081A (pt) 1991-11-29
DE69130544T2 (de) 1999-04-29
FI911367L (fi) 1991-09-23
AU643511B2 (en) 1993-11-18
CA2038706A1 (en) 1991-09-23
HU910958D0 (en) 1991-10-28
EP0449770A3 (en) 1992-07-01
NZ237506A (en) 1992-12-23
BR9101137A (pt) 1991-11-05
NO911138D0 (no) 1991-03-21
KR910016930A (ko) 1991-11-05
DE69130544D1 (de) 1999-01-14
US5559007A (en) 1996-09-24
GB9006400D0 (en) 1990-05-23
FI911367A0 (fi) 1991-03-20
HUT57263A (en) 1991-11-28
IE910948A1 (en) 1991-09-25
EP0449770A2 (en) 1991-10-02
MX25027A (es) 1993-12-01

Similar Documents

Publication Publication Date Title
AR245504A1 (es) Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec.
Buchan et al. Distribution and co-localization of calbindin D28k with VIP and neuropeptide Y but not somatostatin, galanin and substance P in the enteric nervous system of the rat
DK485588A (da) Doseringsform omfattende hurtig (laege)middellevering efterfulgt af langsom (laege)middellevering
FI20011554A7 (fi) Polyetyleeni-proteiinikonjugaatteja
ATE29215T1 (de) Diaethylpropionpraeparate mit verzoegerter wirkung.
CO5271726A1 (es) Composicion farmaceutica soluble en agua en un complejo ionico y el uso de la misma
CY1105917T1 (el) Αναλογα ομοιου με γλυκαγονη πεπτιδιου-1
PA8514401A1 (es) Nuevos derivados de piperazina
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
CO5300417A1 (es) Composiciones de polipeptidos toxicas para insectos antonomus, y metodos de uso
IT1242149B (it) Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
MX9301006A (es) Guanidinas n,n'-disubstituidas y su uso como antaginistas excitadores de aminoacido.
IT8720762A0 (it) Arma combinata, con funzionalita'multipla, per una utilizzazione diversificata.
DE69925371D1 (de) Impfstoff für geflügel
ES507236A0 (es) Un procedimiento para preparar una composicion farmaceutica para aplicacion topica, empleada en el tratamiento del acne.
ES493767A0 (es) Perfeccionamientos, en dispositivos separadores de fibras huecas para el tratamiento de fluidos.
DK1196196T3 (da) Konjugat til formidling af en celle-, compartment- eller membranspecifik transport af aktivstoffer
SHIMIZU Pathogenicity of an infections flacherie virus of the silkworm bombyx mori, obtained from sericultural farms in the suburbs of ina city
AR216571A1 (es) Procedimiento para obtener una enterotoxina e.coli,para su uso como vacuna
IT8020274A0 (it) Poltrona anatomica asimmetrica, particolarmente per uso odontoiatrico.
ATE283061T1 (de) Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
EP4659819A3 (en) A novel furan compound and its use in fragrance formulations
ATE324906T1 (de) Verwendung von chimäres il6-il6r in huntingtonskrankheit
Benenstein Khirbat el-Keik (B)
Traubman Qumran